Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity? - Miranda, Thiago A.; Girardi, Daniel M.; Pereira, Allan A. L. (Chinese Clinical Oncology; Vol 13, No 3 (June 30, 2024): Chinese Clinical Oncology, 2024)